Acorah Software Products - Accounts Production 16.5.460 false true true 31 December 2023 1 January 2023 false 1 January 2024 31 December 2024 31 December 2024 09831900 Ms Pamela Bateson iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 09831900 2023-12-31 09831900 2024-12-31 09831900 2024-01-01 2024-12-31 09831900 frs-core:CurrentFinancialInstruments 2024-12-31 09831900 frs-core:Non-currentFinancialInstruments 2024-12-31 09831900 frs-core:ComputerEquipment 2024-12-31 09831900 frs-core:ComputerEquipment 2024-01-01 2024-12-31 09831900 frs-core:ComputerEquipment 2023-12-31 09831900 frs-core:DevelopmentCostsCapitalisedDevelopmentExpenditure 2024-12-31 09831900 frs-core:DevelopmentCostsCapitalisedDevelopmentExpenditure 2024-01-01 2024-12-31 09831900 frs-core:DevelopmentCostsCapitalisedDevelopmentExpenditure 2023-12-31 09831900 frs-core:OtherReservesSubtotal 2024-12-31 09831900 frs-core:SharePremium 2024-12-31 09831900 frs-core:ShareCapital 2024-12-31 09831900 frs-core:RetainedEarningsAccumulatedLosses 2024-12-31 09831900 frs-bus:PrivateLimitedCompanyLtd 2024-01-01 2024-12-31 09831900 frs-bus:FilletedAccounts 2024-01-01 2024-12-31 09831900 frs-bus:SmallEntities 2024-01-01 2024-12-31 09831900 frs-bus:AuditExempt-NoAccountantsReport 2024-01-01 2024-12-31 09831900 frs-bus:SmallCompaniesRegimeForAccounts 2024-01-01 2024-12-31 09831900 frs-core:FurtherSpecificReserve1ComponentTotalEquity 2024-12-31 09831900 frs-core:CostValuation 2023-12-31 09831900 frs-core:AdditionsToInvestments 2024-12-31 09831900 frs-core:CostValuation 2024-12-31 09831900 frs-core:ProvisionsForImpairmentInvestments 2023-12-31 09831900 frs-core:ProvisionsForImpairmentInvestments 2024-12-31 09831900 frs-bus:Director1 2024-01-01 2024-12-31 09831900 frs-countries:EnglandWales 2024-01-01 2024-12-31 09831900 2022-12-31 09831900 2023-12-31 09831900 2023-01-01 2023-12-31 09831900 frs-core:CurrentFinancialInstruments 2023-12-31 09831900 frs-core:Non-currentFinancialInstruments 2023-12-31 09831900 frs-core:OtherReservesSubtotal 2023-12-31 09831900 frs-core:SharePremium 2023-12-31 09831900 frs-core:ShareCapital 2023-12-31 09831900 frs-core:RetainedEarningsAccumulatedLosses 2023-12-31 09831900 frs-core:FurtherSpecificReserve1ComponentTotalEquity 2023-12-31
Registered number: 09831900
Thrive Partners Ltd
Unaudited Financial Statements
For The Year Ended 31 December 2024
Finerva
Thrive Partners Ltd
Contents
Contents
Page
Balance Sheet 1—2
Notes to the Financial Statements 3—7
Page 1
Thrive Partners Ltd
Balance Sheet
As At 31 December 2024
Balance Sheet
Registered number: 09831900
2024 2023
Notes £ £ £ £
FIXED ASSETS
Intangible Assets 4 1,627,897 1,411,029
Tangible Assets 5 662 -
Investments 6 197 -
1,628,756 1,411,029
CURRENT ASSETS
Debtors 7 299,322 476,639
Cash at bank and in hand 387,931 495,355
687,253 971,994
Creditors: Amounts Falling Due Within One Year 8 (1,267,466 ) (1,215,369 )
NET CURRENT ASSETS (LIABILITIES) (580,213 ) (243,375 )
TOTAL ASSETS LESS CURRENT LIABILITIES 1,048,543 1,167,654
Creditors: Amounts Falling Due After More Than One Year 9 (375,053 ) (549,356 )
PROVISIONS FOR LIABILITIES
Deferred Taxation (145,853 ) (70,708 )
NET ASSETS 527,637 547,590
CAPITAL AND RESERVES
Called up share capital 11 97 97
Share premium account 677,948 677,751
Other reserves 8 8
Share Based Payments Reserve 102,111 77,989
Profit and Loss Account (252,527 ) (208,255 )
SHAREHOLDERS' FUNDS 527,637 547,590
Page 1
Page 2
Thrive Partners Ltd
Balance Sheet (continued)
As At 31 December 2024
For the year ending 31 December 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges her responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
The company has taken advantage of section 444(1) of the Companies Act 2006 and opted not to deliver to the registrar a copy of the company's Profit and Loss Account.
The financial statements were approved by the board of directors on 30 June 2025 and were signed on its behalf by:
Ms Pamela Bateson
Director
30 June 2025
The notes on pages 3 to 7 form part of these financial statements.
Page 2
Page 3
Thrive Partners Ltd
Notes to the Financial Statements
For The Year Ended 31 December 2024
Notes to the Financial Statements
1. General Information
Thrive Partners Ltd is a private company,  limited by shares, incorporated in England & Wales, registered number 09831900 . The registered office is International House, 64 Nile Street, London, N1 7SR.
2. Accounting Policies
2.1. Basis of Preparation of Financial Statements
The financial statements have been prepared under the historical cost convention and in  accordance with Financial Reporting Standard 102 section 1A Small Entities "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006.
2.2. Going Concern Disclosure
The company’s financial statements have been prepared on a going concern basis on the grounds that current and future sources of funding or support will be more than adequate for the company’s needs. In assessing going concern, the directors have a reasonable expectation that the company will continue as a going concern and is able to meet all of its obligations as they fall due for a minimum of 12 months from the date of approval of these financial statements.
2.3. Turnover
Revenue is recognised to the extent there is probable economic benefits will flow to the company and the revenue can be reliably measured. Revenue is measured as the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Revenue from a contract to provide services is recognised in the period in which the services are provided.
2.4. Research and Development
Expenditure on research is written off in the year it is incurred.

Development of intangible assets

Development of intangible assets are initially recognised at cost. After recognition, intangible assets are measured at cost less any accumulated amortization and impairment losses.
All intangible assets are considered to have a finite useful life. The estimated useful lives are as follows:

Development expenditure – 10 years on a straight line basis

At each reporting date the company assesses whether there is any indication of impairment. If such indications exists, the recoverable amount of the asset is determined which is the higher of its fair value less costs to sell and its value in use. Any impairment loss is recognised immediately as an expense within profit or loss.
2.5. Tangible Fixed Assets and Depreciation
Tangible fixed assets are measured at cost less accumulated depreciation and any accumulated impairment losses.  Depreciation  is provided at rates calculated to write off the cost of the fixed assets, less their estimated residual value, over their expected useful lives on the following bases:
Computer Equipment 3 years on a straight line basis
The assets’ residual values, useful lives and depreciation methods are reviewed, and adjusted prospectively if appropriate, or if there is an indication of a significant change since the last reporting date. 
Repairs and maintenance costs are charged to profit or loss during the period in which they are incurred. 
Gains and losses on disposals are determined by comparing the proceeds with the carrying amount and are recognised in profit or loss. 
At each reporting date the company assesses whether there is any indication of impairment. If such indication exists, the recoverable amount of the asset is determined, which is the higher of its fair value less costs to sell and its value in use. Any impairment loss is recognised immediately as an expense within the profit or loss. 
Page 3
Page 4
Thrive Partners Ltd
Notes to the Financial Statements (continued)
For The Year Ended 31 December 2024
2.6. Financial Instruments
Trade and other debtors / creditors

Trade and other debtors are recognised initially at transaction prices less attributable transaction costs. Trade and other creditors are recognised initially at transaction price plus attributable transaction costs. Subsequent to initial recognition they are measured at amortised cost using the effective interest method, less any impairment losses in the case of trade debtors. If the arrangement constitutes a financing transaction, for example if payment is deferred beyond normal business terms, then it is measured at the present value of future payments discounted at a market rate of interest for a similar debt instrument.

Impairment of financial assets

Financial assets that are measured at cost and amortised cost are assessed at the end of each reporting period for objective evidence of impairment. If objective evidence of impairment is found an impairment loss is recognised within profit or loss.

For financial assets that are measured at amortised cost, the impairment loss is measured as the difference between the asset’s carrying amount and the present value of estimated cash flows discounted at the asset’s original effective interest rate.

For financial assets measured at cost less impairment, the impairment loss is measured as the difference between the asset’s carrying amount and the best estimate of the amount that the company would receive for the asset if it were to be sold at the balance sheet date.

2.7. Foreign Currencies
Monetary assets and liabilities in foreign currencies are translated into sterling at the rates of exchange ruling at the balance sheet date.   Transactions in foreign currencies are translated into sterling at the rate ruling on the date of the transaction. Exchange differences are taken into account in arriving at the operating profit.
2.8. Taxation
Income tax expense represents the sum of the tax currently payable and deferred tax.
The tax currently payable is based on taxable profit for the year. Taxable profit differs from profit as reported in the statement of comprehensive income because of items of income or expense that are taxable or deductible in other years and items that are never taxable or deductible. The company's liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the end of the reporting period.
Deferred tax is recognised on timing differences between the carrying amounts of assets and liabilities in the financial statements and the corresponding tax bases used in the computation of taxable profit. Deferred tax liabilities are generally recognised for all taxable timing differences. Deferred tax assets are generally recognised for all deductible temporary differences to the extent that it is probable that taxable profits will be available against which those deductible timing differences can be utilised. The carrying amount of deferred tax assets is reviewed at the end of each reporting period and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow  all or  part of the asset to be recovered.
Deferred tax assets and liabilities are measured at the tax rates that are expected to apply in the period in which the liability is settled or the asset realised, based on tax rates (and tax laws) that have been enacted or substantively enacted by the end of the reporting period. Deferred tax liabilities are presented within provisions for liabilities and deferred tax assets within debtors. The measurement of deferred tax liabilities and assets reflect the tax consequences that would follow from the manner in which the Company expects, at the end of the reporting period, to recover or settle the carrying amount of its assets and liabilities.
Current or deferred tax for the year is recognised in profit or loss, except when they related to items that are recognised in other comprehensive income or directly in equity, in which case, the current and deferred tax is also recognised in other comprehensive income or directly in equity respectively.
2.9. Pensions
The company operates a defined contribution plan for its employees. A defined contribution plan is a pension plan under which the company pays fixed contributions in a separate entity. Once the contributions have been paid the company has no further payment obligations. The contributions are recognised as an expense in profit or loss in the periods during which services are rendered by employees.
Page 4
Page 5
Thrive Partners Ltd
Notes to the Financial Statements (continued)
For The Year Ended 31 December 2024
2.10. Share Based Payments
The grant date fair value of share-based payments awards granted to employees is recognised as an employee expense, with a corresponding increase in equity, over the period in which the employees become unconditionally entitled to the awards. The fair value of the awards granted is measured using an option valuation model, taking in to account the terms and conditions upon which the awards were granted. The amount recognised as an expense is adjusted to reflect the actual number of awards for which the related service and non-market vesting conditions are expected to be met, such that the amount ultimately recognised as an expense is based on the number of awards that do not meet the related service and non-market performance conditions at the vesting date. For share-based payment awards with non-vesting conditions, the grant date fair value of the share-based payment is measured to reflect such conditions and there is no true-up for differences between expected and actual outcomes.
2.11. Investments
Investments relate to an investment in an unlisted entity which is stated at cost less impairment. At each balance sheet date, the investment is assessed for indicators of impairment and where there are indicators of impairment, recoverable amount is assessed. If recoverable amount is less than carrying amount, the investment is written down to recoverable amount by way of an impairment loss which is recognised in profit or loss.
3. Average Number of Employees
Average number of employees during the year was as follows: 9 (2023: 8)
9 8
4. Intangible Assets
Development Costs
£
Cost
As at 1 January 2024 1,855,667
Additions 427,861
As at 31 December 2024 2,283,528
Amortisation
As at 1 January 2024 444,638
Provided during the period 210,993
As at 31 December 2024 655,631
Net Book Value
As at 31 December 2024 1,627,897
As at 1 January 2024 1,411,029
5. Tangible Assets
Computer Equipment
£
Cost
As at 1 January 2024 -
Additions 916
As at 31 December 2024 916
Depreciation
As at 1 January 2024 -
Provided during the period 254
As at 31 December 2024 254
...CONTINUED
Page 5
Page 6
Thrive Partners Ltd
Notes to the Financial Statements (continued)
For The Year Ended 31 December 2024
Net Book Value
As at 31 December 2024 662
As at 1 January 2024 -
6. Investments
Subsidiaries
£
Cost
As at 1 January 2024 -
Additions 197
As at 31 December 2024 197
Provision
As at 1 January 2024 -
As at 31 December 2024 -
Net Book Value
As at 31 December 2024 197
As at 1 January 2024 -
7. Debtors
2024 2023
£ £
Due within one year
Trade debtors 269,051 469,823
Other debtors 30,271 6,816
299,322 476,639
8. Creditors: Amounts Falling Due Within One Year
2024 2023
£ £
Trade creditors 74,135 76,961
Bank loans and overdrafts 51,834 64,857
Other loans 125,000 41,667
Other creditors 924,720 968,498
Taxation and social security 91,777 63,386
1,267,466 1,215,369
Incldued within other creditors are outstanding pension contributions of £4,686 (2023: £7,637)
9. Creditors: Amounts Falling Due After More Than One Year
2024 2023
£ £
Bank loans 52,136 91,023
Other loans 322,917 458,333
375,053 549,356
Page 6
Page 7
Thrive Partners Ltd
Notes to the Financial Statements (continued)
For The Year Ended 31 December 2024
10. Secured Creditors
Other loans includes an amount of £447,917 (2023: £500,000) which is secured by a fixed and floating charge over the assets of the company.
11. Share Capital
2024 2023
£ £
Allotted, Called up and fully paid 97 97
12. Share Based Payments
The company operates two equity based share option schemes (an approved EMI and an unapproved scheme) to certain employees which provide additional remuneration for those employees who are key to the company. The options expire ten years after the date of the grant. Employees are not entitled to dividends until the shares are exercised. All options granted have performance conditions relating to the relevant employee remaining in the employment of the company at exercise.
A reconciliation of share option movements during the year ended 31 December 2024 is shown below:
Number of options - weighted average exercise price
Granted prior to 1 January 2024:           274,626 - £0.02
Granted during the year:                        55,327 - £0.02
Forfeited during the year:                     (10,650) - £0.02
Exercised during the year:                      (9,872) - £0.02
Outstanding as at 31 December 2024:    309,431 - £0.02
The company is unable to directly measure the fair value of the share options. Instead the fair value of the share options granted during the year is determined using the Black-Scholes model. The model is internationally recognised as being appropriate to value share option schemes similar to that of the company.
Equity settled schemes - charges arising: £31,240 (2023: £77,989)
Page 7